Participation in Clinical Research Could Modify Background Risk for Trial Outcome Measures

Abstract
Data on HIV incidence and retention are needed to inform study design of efficacy trials. However, the selection criteria and interventions during an actual clinical trial could reduce HIV incidence and thus affect the statistical power. We investigated the effect of inclusion and participation in a simulated vaccine efficacy trial (SiVET) on HIV and pregnancy incidence in a fisherfolk cohort in SW Uganda.
Description
Keywords
Clinical Research, Risk, Trial Outcome Measures
Citation
Abaasa, A. M., Asiki, G., Levin, J., Bahemuka, U., Ruzagira, E., Kibengo, F. M., ... & Kamali, A. (2014). Participation in Clinical Research Could Modify Background Risk for Trial Outcome Measures. AIDS Research and Human Retroviruses, 30(S1), A213-A214. https://doi.org/10.1089/aid.2014.5462.abstract